SWAT Medical v Meril Italy (CFI, 14 October 2024)
| Date | 14 October 2024 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Application RoP262.1 (b) |
| Registry reference | App_33486/2024 · ORD_36095/2024 |
| Parties | KIPA AB |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 14 October 2024 (ORD_36095/2024, App_33486/2024, App_33487/2024, App_33489/2024), the judge-rapporteur of the Paris Central Division (P. Catallozzi) granted SWAT Medical and a board member and investor of that company access to all pleadings and evidence in revocation action UPC_CFI_255/2023 and counterclaims CC_584916/2023 and CC_585030/2023 between Meril and Edwards Lifesciences concerning EP 3 646 825. He granted leave to appeal and suspended the effect of access pending the appeal.
Question
May a third party with only a generic interest obtain access to all the pleadings in proceedings, and can such access be limited or made subject to confidentiality obligations?
Decision
The applicant must state the purpose of the request and why the documents sought are needed (paragraph 15). Once proceedings have ended, the concern for their integrity no longer applies and the balance of interests under Art. 45 UPCA normally favours access (paragraphs 17 and 18). Operating in the same field as the patent is not enough to establish a specific interest (paragraph 19), but preparatory steps to enter the relevant market justify access (paragraph 20). Access is not limited to the validity documents (paragraphs 24 to 26), and the use of public court records in business is not in itself unlawful, so no confidentiality obligation is imposed (paragraphs 27 to 31). As access is practically irreversible, leave to appeal is granted to secure consistent case law and the order is suspended (paragraphs 32 and 33).
Key points for practice
- Practical point: once proceedings have ended, a third party preparing to enter the market will in principle obtain access to all documents, with no restriction on use, a party resisting access must point to specific confidential information.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 10(1) and 45
- Rules of Procedure
- Rule 262.1(b)
- Case law cited
- Ocado v Autostore, Court of Appeal, 10 April 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Confidentiality club.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantKIPA AB8 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application RoP262.1 (b)
- Outcome (Dhenne Avocats summary)
- SWAT Medical obtient l'accès à toutes les écritures et preuves de l'instance entre Meril et Edwards, sans limitation ni obligation de confidentialité. L'appel est autorisé et l'ordonnance suspendue.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.